Disruption of lipid rafts stimulates phospholipase D activity in human lymphocytes: Implication in the regulation of immune function

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8077-8086

  Diaz, Olivier ^a   Mébarek Azzam, Saïda ^a   Benzaria, Amal ^a   Dubois, Madeleine ^a   Lagarde, Michel ^a   Némoz, Georges ^a   Prigent, Annie France ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL SPHINGOMYELINASE; CERAMIDE; FILIPIN; INTERLEUKIN 2; MESSENGER RNA; METHYL BETA CYCLODEXTRIN; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRITON X 100; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIPID RAFT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMBRANE BINDING; MITOGENESIS; PRIORITY JOURNAL; SUCROSE DENSITY GRADIENT CENTRIFUGATION;

EID: 29144480539     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8077     Document Type: Article

References (55)

1. Nozawa, Y. 2002. Roles of phospholipase D in apoptosis and pro-survival. Biochim. Biophys. Acta 1585: 77-86.
2. McDermott, M., M. J. O. Wakelam, and A. J. Morris. 2004. Phospholipase D. Biochem. Cell Biol. 82: 225-253.
3. Gibbs, T. C., and K. E. Meier. 2000. Expression and regulation of phospholipase D isoforms in mammalian cell lines. J. Cell. Physiol. 182: 77-87.
4. Fra, A. M., E. Williamson, K. Simons, and R. G. Parton. 1994. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J. Biol. Chem. 269: 30745-30748.
5. Diaz, O., A. Berquand, M. Dubois, S. Di Agostino, C. Sette, S. Bourgoin, M. Lagarde, G. Némoz, and A. F. Prigent. 2002. The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts. J. Biol. Chem. 277: 39368-39378.
6. Stewart, S. J., G. R. Cunningham, J. A. Strupp, F. S. House, L. L. Kelley, G. S. Henderson, J. H. Exton, and S. B. Bocckino. 1991. Activation of phospholipase D: a signaling system set in motion by perturbation of the T lymphocyte antigen receptor/CD3 complex. Cell Regul. 2: 841-850.
7. Reid, P. A., S. D. Gardner, D. M. Williams, and M. M. Harnett. 1997. The antigen receptors on mature and immature T lymphocytes are coupled to phosphatidylcholine-specific phospholipase D activation. Immunology 90: 250-2256.
8. Kinsky, S. C., J. E. Loader, and S. H. Benedict. 1989. Phorbol ester activation of phospholipase D in human monocytes but not peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 162: 788-793.
9. Biffen, M., M. Shiroo, and D. R. Alexander. 1993. Selective coupling of the T cell antigen receptor to phosphoinositide-derived diacylglycerol production in HPB-ALL T cells correlates with CD45-regulated p59fyn activity. Eur. J. Immunol. 23: 2980-2987.
10. Aussel, C., C. Pelassy, and J.-P. Breittmayer. 1992. A diacylglycerol kinase is involved in the regulation of interleukin-2 synthesis in Jurkat T cells. Cell. Immunol. 139: 333-341.
11. Zakaroff-Girard A., S. El Bawab, G. Némoz, M. Lagarde, and A. F. Prigent. 1999. Relationships between phosphatidic acid and cyclic nucleotide phosphodiesterases in activated human blood mononuclear cells. J. Leukocyte Biol. 65: 381-390.
12. Bechoua, S., M. Dubois, G. Némoz, M. Lagarde, and A. F. Prigent. 1998. Docosahexaenoic acid lowers phosphatidate level in human activated lymphocytes despite phospholipase D activation. J. Lipid Res. 39: 873-883.
13. Meskini, N., A. Zakaroff, C. Joulain, G. Némoz, M. Lagarde, and A. F. Prigent. 1995. Triggering of a phospholipase D pathway upon mitogenic stimulation of human peripheral blood mononuclear cells enriched with 12(S)-hydroxyicosatetraenoic acid. Eur. J. Biochem. 233: 907-915.
14. Joulain, C., M. Guichardant, M. Lagarde, and A. F. Prigent. 1995. Influence of polyunsaturated fatty acids on lipid metabolism in human blood mononuclear cells and early biochemical events associated with lymphocyte activation. J. Lipid Med. Cell Signal. 11: 63-79.
15. Gilbert, J. J., T. R. Pettitt, S. D. Seatter, S. D. Reid, M. J. O. Wakelam, and M. M. Harnett. 1998. Antagonistic roles for phospholipase D activities in B cell signaling: while the antigen receptors transduce mitogenic signals via a novel phospholipase D activity, phosphatidylcholine-phospholipase D mediates anti-proliferative signals. J. Immunol. 161: 6575-6584.
16. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. [Published erratum appears in 2001 Nat. Rev. Mol. Cell Biol. 2: 216.] Nat. Rev. Mol. Cell Biol. 1: 31-39
17. Mendez, A. J., L. Guorong, D. P. Wade, R. M. Lawn, and J. F. Oram. 2001. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated secretory pathway. J. Biol. Chem. 276: 3158-3166.
18. Rothenberg, E. V., and S. B. Ward. 1996. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc. Natl. Acad. Sci. USA 93: 9358-9365.
19. Boukhchache, D., and M. Lagarde. 1982. Interaction between prostaglandin precursors during their oxygenation by human platelets. Biochim. Biophys. Acta 713: 386-392.
20. Schaffner, W., and C. Weissmann. 1973. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56: 502-514.
21. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. 1986. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261: 8597-8600.
22. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
23. Veldman, R. J., N. Maestre, O. M. Aduib, J. A. Medin, R. Salvayre, and T. Levade. 2001. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem. J. 355: 859-868.
24. Ilangumaran, S., and D. C. Hoessli. 1998. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem. J. 335: 433-440.
25. Kabouridis, P. S., J. Janzen, A. L. Magee, and S. C. Ley. 2000. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur. J. Immunol. 30: 954-963.
26. 2 in human T cell proliferation. FEBS Lett. 520: 111-116.
27. Morash, S. C., D. M. Byers, and H. W. Cook. 2000. Activation of phospholipase D by PKC and GTPγS in human neuroblastoma cells overexpressing MARCKS. Biochim. Biophys. Acta 1487: 177-189.
28. Barabé, F., G. Paré, M. J. G. Fernandez, S. Bourgoin, and P. Naccache. 2002. Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. J. Biol. Chem. 277: 13473-13478.
29. Munro, S. 2003. Lipid rafts: elusive or illusive? Cell 115: 377-388.
30. Cremesti, A. E., F. M. Goni, and R. Kolesnick. 2002. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic-outcome? FEBS Lett. 531: 47-53.
31. Meacci, E., V. Vasta, S. Neri, M. Farnararo, and P. Bruni. 1996. Activation of phospholipase D in human fibroblasts by ceramide and sphingosine: evaluation of their modulatory role in bradykinin stimulation of phospholipase D. Biochem. Biophys. Res. Commun. 225: 392-399.
32. Liu, G., L. Kleine, R. Nasrallah, and R. L. Hébert. 1999. Bradykinin inhibits-ceramide production and activates phospholipase D in rabbit cortical collecting duct cells. Am. J. Physiol. 276: F589-F598.
33. Chen, J.-S., M.-Q. Chai, H.-H. Chen, S. Zhao, and J.-G. Song. 2000. Regulation of phospholipase D activity and ceramide production in daunorubicin-induced apoptosis in A-431 cells. Biochim. Biophys. Acta 1488: 219-232.
34. Kolesnick, R. N., F. M. Goni, and A. Alonso. 2000. Compartmentalization of ceramide signaling: physical foundations and biologic effects. J. Cell. Physiol. 184: 285-300.
35. Ito, J.-I., Y. Nagayasu, and S. Yokoyama. 2000. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J. Lipid Res. 41: 894-904.
36. London, M., and E. London. 2004. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts). J. Biol. Chem. 279: 9997-10004.
37. Kim, J. H., J. M. Han, S. Lee, Y. Kim, T. G. Lee, J. B. Park, S. D. Lee, P.-G. Suh, and S. H. Ryu. 1999. Phospholipase D1 in caveolae: regulation by protein kinase Cα and caveolin-1. Biochemistry 38: 3763-3769.
38. Sundaram, M., H. W. Cook, and D. M. Byers. 2004. The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem. Cell Biol. 82: 191-200.
39. Glaser, M., S. Wanaski, C. A. Buser, V. Boguslavsky, W. Rashidzada, A. Morris, M. Rebecchi, S. F. Scarlata, L. W. Runnels, G. D. Prestwich, et al. 1996. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J. Biol. Chem. 271: 26187-26193.
40. Kusner, D. J., J. A. Barton, K. K. Wen, X. Wang, P. A. Rubenstein, and S. S. Iyer. 2002 Regulation of phospholipase D activity by actin: actin exerts bidirectional modulation of Mammalian phospholipase D activity in a polymerization-dependent, isoform-specific manner. J. Biol. Chem. 277: 50683-50692.
41. Calder, P. C., P. Yaqoob, F. Thies, F. A. Wallace, and E. A. Miles. 2002. Fatty acids and lymphocyte functions. Br. J. Nutr. 87: S31-S48.
42. Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8: 723-732.
43. Pizzo, P., E. Giurisato, M. Tassi, A. Benedetti, T. Pozzan, and A. Viola. 2002. Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 32: 3082-3091.
44. Horejsi, V. 2002. Membrane rafts in immunoreceptor signaling: new doubts, new proofs? Trends Immunol. 23: 562-564.
45. Jolly, C. A., J. C. Laurenz, D. N. McMurray, and R. S. Chapkin. 1996. Diacylglycerol and ceramide kinetics in primary cultures of activated T lymphocytes. Immunol. Lett. 49: 43-48.
46. Pizzo, P., and A. Viola. 2004. Lipid rafts in lymphocyte activation. Microbes Infect. 6: 686-692.
47. Meier, K. E., T. C. Gibbs, S. M. Knoepp, and K. M. Ella. 1999. Expression of phospholipase D isoforms in mammalian cells. Biochim. Biophys. Acta 1439: 199-213.
48. Choi, W. S., Y. M. Kim, C. Combs, M. A. Frohman, and M. A. Beaven. 2002. Phospholipases D1 and D2 regulate different phases of exocytosis in mast cells. J. Immunol. 168: 5682-5689.
49. Noronha, A., A. Toscas, and M. A. Jensen. 1993. Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J. Neuroimmunol. 46: 145-153.
50. Cataldi, A., A. Caracino, A. Di Baldassarre, I. Robuffo, and S. Miscia. 1995. Interferon β mediated intracellular signalling traffic in human lymphocytes. Cell. Signal. 7: 627-633.
51. Hodgkin, M. N., T. R. Pettitt, A. Martin, R. H. Michell, A. J. Pemberton, and M. I. Wakelam. 1998. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23: 200-204.
52. Frank, C., H. Keilhack, F. Opitz, O. Zschörmig, and F.-D. Böhmer. 1999. Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation. Biochemistry 38: 11993-12002.
53. Sathish, J. G., J. Walters, J. C. Luo, K. G. Johnson, F. G. LeRoy, P. Brennan, K. P. Kim, S. P. Gyg, B. G. Neel, and R. J. Matthews. 2004. CD22 is a functional ligand for SHP-1 in primary T cells. J. Biol. Chem. 279: 47783-47791.
54. Hao, S., and A. August. 2005. Actin depolymerization transduces the strength of B cell receptor stimulation. Mol. Biol. Cell 216: 2275-2284.
55. Baumann, S., A. Krueger, S. Kirchhoff, and P. H. Krammer. 2002. Regulation of T cell apoptosis during the immune response. Curr. Mol. Med. 2: 257-272.